Induced Pluripotent Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030

Induced Pluripotent Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030

Induced Pluripotent Stem Cell Trends and Forecast

The future of the global induced pluripotent stem cell market looks promising with opportunities in the research & academic institute, biotechnology & pharmaceutical company, and hospital & clinic markets. The global induced pluripotent stem cell market is expected to reach an estimated $2.6 billion by 2030 with a CAGR of 10.3% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer, amplified financial investments in stem cell research, and the numerous benefits of induced pluripotent stem cells (iPSCs) compared to embryonic stem cells (ESCs).

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Induced Pluripotent Stem Cell by Segment

The study includes a forecast for the global induced pluripotent stem cell by workflow, application, end use, and region.

Induced Pluripotent Stem Cell Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

• Reprogramming
• Cell Culture
• Cell Characterization / Analysis
• Engineering
• Others

Induced Pluripotent Stem Cell Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Drug Development & Discovery
• Regenerative Medicine
• Toxicology Studies
• Others

Induced Pluripotent Stem Cell Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Research & Academic Institutes
• Biotechnology & Pharmaceutical Companies
• Hospitals & Clinics

Induced Pluripotent Stem Cell Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Induced Pluripotent Stem Cell Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies induced pluripotent stem cell companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the induced pluripotent stem cell companies profiled in this report include-

• Lonza
• Axol Bioscience
• Evotec
• Hitachi
• Reprocell
• Merck
• Reprocells
• Fate Therapeutics
• Thermo Fisher Scientific
• Stemcellsfactory III

Induced Pluripotent Stem Cell Market Insights

Lucintel forecasts that drug development & discovery will remain the largest segment over the forecast period because the chronic illnesses are spreading throughout the world.

APAC is expected to witness fastest growth over the forecast period due to robust, cost-effective focus on stem cell-based research, the expansion of economies, improvements in healthcare strategies, and the increasing recognition of the promise of personalized treatments.

Features of the Global Induced Pluripotent Stem Cell Market

Market Size Estimates: Induced pluripotent stem cell market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Induced pluripotent stem cell market size by workflow, application, end use, and region in terms of value ($B).

Regional Analysis: Induced pluripotent stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different workflow, application, end use, and regions for the induced pluripotent stem cell market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the induced pluripotent stem cell market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the induced pluripotent stem cell market size?

Answer: The global induced pluripotent stem cell market is expected to reach an estimated $2.6 billion by 2030.

Q.2 What is the growth forecast for induced pluripotent stem cell market?

Answer: The global induced pluripotent stem cell market is expected to grow with a CAGR of 10.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the induced pluripotent stem cell market?

Answer: The major drivers for this market are rising prevalence of cancer, amplified financial investments in stem cell research, and the numerous benefits of induced pluripotent stem cells (iPSCs) compared to embryonic stem cells (ESCs).

Q4. What are the major segments for induced pluripotent stem cell market?

Answer: The future of the global induced pluripotent stem cell market looks promising with opportunities in the research & academic institute, biotechnology & pharmaceutical company, and hospital & clinic markets.

Q5. Who are the key induced pluripotent stem cell market companies?

Answer: Some of the key induced pluripotent stem cell companies are as follows:

• Lonza
• Axol Bioscience
• Evotec
• Hitachi
• Reprocell
• Merck
• Reprocells
• Fate Therapeutics
• Thermo Fisher Scientific
• Stemcellsfactory III

Q6. Which induced pluripotent stem cell market segment will be the largest in future?

Answer: Lucintel forecasts that drug development & discovery will remain the largest segment over the forecast period because the chronic illnesses are spreading throughout the world.

Q7. In induced pluripotent stem cell market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness fastest growth over the forecast period due to robust, cost-effective focus on stem cell-based research, the expansion of economies, improvements in healthcare strategies, and the increasing recognition of the promise of personalized treatments.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the induced pluripotent stem cell market by workflow (reprogramming, cell culture, cell characterization / analysis, engineering, and others), application (drug development & discovery, regenerative medicine, toxicology studies, and others), end use (research & academic institutes, biotechnology & pharmaceutical companies, and hospitals & clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.